Blood-Clot Medicine Adjustment After Minor Stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether doctors can safely reduce the strength of blood-thinning medications after a minor stroke by measuring how well your blood clots. The goal is to find the right dose that protects you without increasing bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a minor stroke or TIA (mini-stroke) within the last 48 hours
- Your stroke severity is mild (specific scoring system shows low risk)
- You took two blood-thinning drugs (clopidogrel and aspirin) within 48 hours of symptom onset
- A blood test 5–20 hours later showed your blood clotting response was below a certain threshold
- You are willing to take aspirin and/or clopidogrel for the duration of the trial
- You do not have bleeding disorders, recent major bleeding, or conditions requiring blood thinners like warfarin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial compares two ways to treat a minor acute ischemic stroke: aspirin plus clopidogrel versus an IV clot-busting medicine (alteplase). It aims to see which approach works better and is safer when symptoms start within 4.5 hours.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial studies whether using blood-thinning medicine is safe and appropriate for people after an ischemic stroke who also have small signs of bleeding in the brain. It aims to balance stroke prevention with the risk of bigger bleeding.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.